Latest filings (excl ownership)
15-12G
Securities registration termination
15 Apr 24
EFFECT
Notice of effectiveness
9 Apr 24
25-NSE
Exchange delisting
5 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Apr 24
POS AM
Prospectus update (post-effective amendment)
5 Apr 24
8-K
NGM Bio Announces Closing of Tender Offer
5 Apr 24
SC 13E3/A
Going private transaction (amended)
5 Apr 24
SC 13E3/A
Going private transaction (amended)
5 Apr 24
SC 14D9/A
Tender offer solicitation (amended)
5 Apr 24
SC 14D9/A
Tender offer solicitation (amended)
29 Mar 24
SC 13E3/A
Going private transaction (amended)
22 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
22 Mar 24
SC 13E3/A
Going private transaction (amended)
22 Mar 24
10-K
2023 FY
Annual report
11 Mar 24
8-K
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 24
SC 13E3
Going private transaction
8 Mar 24
SC 14D9
Tender offer solicitation
8 Mar 24
SC 13E3
Going private transaction
8 Mar 24
SC TO-T
Third party tender offer statement
8 Mar 24
SC14D9C
Written communication relating to third party tender offer
26 Feb 24
8-K
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
26 Feb 24
SC TO-C
Information about tender offer
26 Feb 24
8-K
Other Events
22 Jan 24
8-K
Other Events
2 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Dec 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights
2 Nov 23
8-K
Departure of Directors or Certain Officers
17 Oct 23
8-K/A
Departure of Directors or Certain Officers
11 Sep 23
8-K
Departure of Directors or Certain Officers
11 Aug 23
EFFECT
Notice of effectiveness
7 Aug 23
424B5
Prospectus supplement for primary offering
4 Aug 23
S-3/A
Shelf registration (amended)
4 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
NGM Bio Reports Second Quarter 2023 Financial Results and Provides Business Highlights
3 Aug 23
Latest ownership filings
4
Change in insider ownership
8 Apr 24
4
Change in insider ownership
8 Apr 24
4
Peter Svennilson
8 Apr 24
4
DAVID V GOEDDEL
8 Apr 24
4
Valerie L Pierce
8 Apr 24
4
WILLIAM JL RIEFLIN
8 Apr 24
4
Jean-Frederic Viret
8 Apr 24
4
DAVID J WOODHOUSE
8 Apr 24
4
Irene Perlich
8 Apr 24
4
Carole Ho
8 Apr 24
4
Shelly D Guyer
8 Apr 24
4
Suzanne Sawochka Hooper
8 Apr 24
4
ROGER M PERLMUTTER
8 Apr 24
4
Hsiao D Lieu
8 Apr 24
SC 13D/A
COLUMN GROUP L P
5 Apr 24
SC 13D/A
COLUMN GROUP L P
26 Feb 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Hsiao D Lieu
18 Jan 24
4
Irene Perlich
18 Jan 24
4
Valerie L Pierce
18 Jan 24
4
DAVID J WOODHOUSE
18 Jan 24
SC 13D/A
COLUMN GROUP L P
29 Dec 23
4
Jean-Frederic Viret
4 Dec 23
4
Change in insider ownership
17 Nov 23
4
Change in insider ownership
17 Nov 23
4
Peter Svennilson
17 Nov 23
4
DAVID V GOEDDEL
17 Nov 23
3
Jean-Frederic Viret
8 Nov 23
4
Valerie L Pierce
8 Nov 23
4
Irene Perlich
8 Nov 23
4
DAVID J WOODHOUSE
8 Nov 23
4
Hsiao D Lieu
8 Nov 23
SC 13G/A
BlackRock Inc.
6 Oct 23
3
Irene Perlich
18 Sep 23
4
Shelly D Guyer
12 May 23
4
WILLIAM JL RIEFLIN
12 May 23
4
Suzanne Sawochka Hooper
12 May 23
4
DAVID V GOEDDEL
12 May 23
4
ROGER M PERLMUTTER
12 May 23